Regulus Therapeutics Inc (NASDAQ:RGLS)

0.72
Delayed Data
As of May 23
 +0.0198 / +2.83%
Today’s Change
0.63
Today|||52-Week Range
1.60
-30.77%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
AssetsCash37.3M17.2M14.9M13.5M
 
 
 
 
 
Short Term Investment Cash19.5M-21.4M-1.0M-1.4M
 
 
 
 
 
Cash & Short Term Investments159.7M115.3M76.1M60.1M
 
 
 
 
 
 
ReceivablesReceivables274.0K10.0M1.7M373.0K
 
 
 
 
 
 
InventoriesInventories--0.005.6M4.8M
 
 
 
 
Current AssetsPrepaid Expenses--8.2M----
 
 
Other Current Assets4.9M759.0K4.2M1.5M
 
 
 
 
 
Current Assets165.0M134.3M87.5M66.7M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross8.7M11.9M19.6M18.0M
 
 
 
 
 
Depreciation-5.2M-6.5M-7.8M-8.3M
 
 
 
 
 
Intangible Assets1.2M1.1M1.0M775.0K
 
 
 
 
 
Other Assets3.0M1.4M1.4M1.4M
 
 
 
 
 
Total Assets171.5M141.1M100.7M77.8M
 
 
 
 
 
 
LiabilitiesAccounts Payable2.2M2.7M5.8M5.7M
 
 
 
 
 
Short Term Debt23.4M0.000.0019.9M
 
 
 
Accrued Expenses4.4M6.3M5.6M4.9M
 
 
 
 
 
Other Current Liabilities7.5M7.5M5.6M5.0M
 
 
 
 
 
Other Liabilities35.2M12.6M13.8M32.6M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt0.000.0019.8M0.00
 
 
Other Liabilities322.0K2.3M144.0K8.1M
 
 
 
 
 
Total Liabilities39.5M17.0M44.6M42.6M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity132.0M124.1M56.1M35.2M
 
 
 
 
 
Total Shareholder Equity132.0M124.1M56.1M35.2M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding48.9M52.7M52.9M104.0M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.